OHA:口服降糖药
“口服降糖药”在医学和生理学领域常被简称为“OHA”,这一缩写形式便于快速书写和日常使用。作为一种常见的医学术语,OHA主要用于指代通过口服方式调节血糖的药物,广泛应用于糖尿病等代谢性疾病的临床治疗场景中。该简称有效提升了专业交流与病历记录的效率。
Oral Hypoglycemic Agent具体释义
Oral Hypoglycemic Agent的英文发音
例句
- Thirty-four NIDDM patients were given 4-month dietary control and / or oral hypoglycemic agent treatment and it showed that the GFR, kidney volume and UAE were partially reduced in 12 patients with improved metabolic control;
- 34例NIDDM患者经饮食控制和/或口服降糖药(OHA)治疗4个月后进行了复查,结果显示:12例代谢改善者的GFR、肾脏体积和UAE有不同程度的恢复;
- Combination therapy with insulin and oral hypoglycemic agent for type ⅱ diabetes
- 胰岛素和口服降糖药(OHA)合用治疗Ⅱ型糖尿病
- Clinical Application of Oral Hypoglycemic Agent(OHA) to Diabetes
- 糖尿病口服降糖药(OHA)的临床应用进展
- Nateglinide is a novel oral hypoglycemic agent used in type 2 diabetes. It is absorbed and eliminated in short time and made the blood glucose of diet in physiological control.
- 那格列奈是一种新型的治疗2型糖尿病的口服药物,它能够被快速吸收和消除,从而使膳食时的血糖得到生理性控制。
- Clinical Report on Correction of HbAlc Level in Diabetes ⅱ with Secondary Failure of Oral Hypoglycemic Agent(OHA) by Chinese Herbs
- 中药纠正口服降糖药(OHA)物继发失效Ⅱ型糖尿病HbAlc水平的临床报道
本站英语缩略词为个人收集整理,可供非商业用途的复制、使用及分享,但严禁任何形式的采集或批量盗用
若OHA词条信息存在错误、不当之处或涉及侵权,请及时联系我们处理:675289112@qq.com。